Gene therapy in The Netherlands: highlights from the Low Countries

Gene therapy is an active research area in The Netherlands and Dutch scientists involved in fundamental and clinical gene therapy research significantly contribute to the progresses made in this field. This ranges from the establishment of the 293, 911 and PER.C6 cell lines, which are used worldwide for the production of replication-defective adenoviral vectors, to the development of targeted viral vectors and T lymphocytes as well as of non-viral vectors. Several milestones have been achieved in Dutch clinical gene therapy trials, including the first treatment worldwide of patients with adenosine deaminase deficiency with genetically corrected hematopoietic stem cells in collaboration with French and British scientists. Until now, about 230 patients with various diseases have been treated with viral and non-viral gene therapy in this country. Ongoing and upcoming Dutch clinical trials focus on the translation of new developments in gene therapy research, including the restoration of genetic defects other than SCID, and the use of oncolytic adenoviruses and targeted T cells for the treatment of cancer. The growing commercial interest in Dutch clinical gene therapy is reflected by the involvement of two Dutch companies in ongoing trials as well as the participation of Dutch clinical centres in large phase III international multicenter immuno-gene therapy trials on prostate cancer sponsored by an American company. Translational gene therapy research in The Netherlands is boosted at a governmental level by the Dutch Ministry of Health via a dedicated funding programme. This paper presents an overview on milestones in Dutch basic gene therapy research as well as on past, present and future clinical gene therapy trials in The Netherlands.     

Ecological Risk Assessment and Regulation for Genetically-Modified Ornamental Plants

Classic plant breeding has increased the beauty and utility of ornamental plants, but biotechnology can offer completely new traits for plants used in homes and gardens. The creation of blue petal color in carnations and roses are examples where biotechnology has created novelty that conventional hybridization cannot match. However, all innovations have benefits and risks, and future commercialization of transgenic ornamental plants raises complex questions about potential negative impacts to managed landscapes and natural ecosystems. Predictive ecological risk assessment is a process that uses current knowledge to estimate future environmental harms or benefits arising from direct or indirect exposure to a genetically-modified (GM) plant, its genes, or gene products. This article considers GM ornamental plants in the context of current ecological risk assessment principles, research results, and current regulatory frameworks. The use of ecological risk assessment by government agencies to support decision-making is reviewed in the context of ornamental plants. Government risk assessments have usually emphasized the potential for pollen-mediated gene flow, weediness in managed areas, invasion of natural areas, and direct harm to nontarget organisms. Some of the major challenges for predictive risk assessment include characterizing gene flow over time and space, plant fitness in changing environments, and impacts to nontarget organisms, communities and ecosystems. The lack of baseline information about the ecology and biodiversity of urban areas, gardens, and natural ecosystems limits the ability to predict potential hazards, identify exposure pathways, and design hypothesis-driven research. The legacy of introduced ornamental plants as invasive species generates special concern about future invasions, especially for GM plants that exhibit increased stress tolerance or adaptability. While ecological risk assessments are a valuable tool and have helped harmonize regulation of GM plants, they do not define the acceptable level of risk or uncertainty. That responsibility belongs to regulators, stakeholders and citizens.     

转基因作物中2种除草剂抗性基因aad1和dmo的PCR检测方法

【背景】抗除草剂转基因作物是全球种植面积最大的一类转基因植物,以除草剂抗性基因作为检测靶标的分子鉴定方法的研究与应用,对转基因生物安全的检测与监测有重要意义。【方法】根据除草剂抗性基因aad1和dmo的核苷酸序列设计PCR检测引物,并进行PCR反应体系优化、方法特异性、灵敏度、再现性等方面的测试,分别建立aad1基因和dmo基因的特异性PCR检测方法。【结果】建立的PCR检测方法在56~64℃的退火温度范围内均能获得一致性结果,具有良好的稳健性。该方法可将含有aad1基因和dmo基因的转基因作物与其他转基因作物区分开,其灵敏度可分别达到20个拷贝和40个拷贝。通过将aad1基因和dmo基因的检测引物放入同一管PCR反应体系中,还能在一次PCR中同时检测这2个靶标基因,双重PCR的检测灵敏度与单一PCR一致。【结论与意义】建立的分子方法可精准检测出含有aad1基因和dmo基因的转基因作物,具有特异性强、灵敏度高的特点,为抗除草剂转基因作物的筛选检测提供了可靠的技术支撑。     

关于加强我国生物安全工作若干问题的思考

随着现代化生物技术,特别是基因工程技术的兴起和迅速发展,生物安全问题农渐成为全球社会普遍关注的热点,它既是一个科学问题,又是一个管理问题,需要从健全法律法规体系,理顺管理机构体系,支持鼓励科学研究,重视科学宣传普及,加强相关国际合作等方面,大力加强我国的生物安全工作,达到保障安全,促进发展的目标。     

Competitive interactions and the effect of herbivory on Bt-Brassica napus, Brassica rapa and Lolium perenne

1.  The probability of a transgenic crop establishing a feral population outside cultivated areas and possibly outcompeting naturally occurring species needs to be assessed to make an ecological risk assessment of the transgenic crop.
2.  The interaction between herbivory and competition is thought to determine the ecological success of insect-resistant plants, and this interaction was investigated in a competition experiment with transgenic insect-resistant Bt- Brassica napus , Brassica rapa , Lolium perenne , and herbivory from the large white butterfly Pieris brassicae .
3.  As expected, herbivory had a negative effect on the biomass of B. rapa at high plant densities. The competitive ability of L. perenne , when growing with B. rapa , increased significantly with the level of herbivory on B. rapa .
4.  To predict the effect of herbivory in a natural ecosystem, plant competition between the two annual Brassica species was analysed in a population ecological model. It was concluded that it is probable that transgenic Bt- B. napus plants may invade a natural habitat if herbivory is sufficiently high and the habitat is suitable for B. napus .
5.   Synthesis and applications . The results indicate that it is important to study the interaction between herbivory and competition when assessing the ecological risk of insect-resistant genetically modified crops. Furthermore, combining ecological data from manipulated experiments with population ecological modelling is a fruitful approach when conducting environmental risk assessments.     

Mitigation of indirect environmental effects of GM crops

Currently, the UK has no procedure for the approval of novel agricultural practices that is based on environmental risk management principles. Here, we make a first application of the 'bow-tie' risk management approach in agriculture, for assessment of land use changes, in a case study of the introduction of genetically modified herbicide tolerant (GMHT) sugar beet. There are agronomic and economic benefits, but indirect environmental harm from increased weed control is a hazard. The Farm Scale Evaluation (FSE) trials demonstrated reduced broad-leaved weed biomass and seed production at the field scale. The simplest mitigation measure is to leave a proportion of rows unsprayed in each GMHT crop field. Our calculations, based on FSE data, show that a maximum of 2% of field area left unsprayed is required to mitigate weed seed production and 4% to mitigate weed biomass production. Tilled margin effects could simply be mitigated by increasing the margin width from 0.5 to 1.5 m. Such changes are cheap and simple to implement in farming practices. This case study demonstrates the usefulness of the bow-tie risk management approach and the transparency with which hazards can be addressed. If adopted generally, it would help to enable agriculture to adopt new practices with due environmental precaution.     

Evaluation of the potential exposure of butterflies to genetically modified maize pollen in protected areas in Italy

Environmental impacts of genetically modified crops are mandatorily assessed during their premarket phase. One of the areas of concern is the possible impact on nontarget organisms. Crops expressing Cry toxins might affect Lepidoptera larvae living outside cultivated fields, through pollen deposition on wild plants, which constitute their food source. While pollen toxicity varies among different events, possible exposure of nontarget species depends on the agro‐environmental conditions. This study was conducted in two protected areas in Italy, characterized by different climatic conditions, where many Lepidoptera species thrive in proximity to maize cultivations. To estimate the possible exposure in absence of the actual stressor (e.g., Cry1‐expressing maize plants), we conducted a two‐year field survey of butterflies and weeds. Indicator species were selected—Aglais (Inachis) io in the Northern site and Vanessa cardui in the Southern site—and their phenology was investigated. Pollen dispersal from maize fields was measured by collection in Petri dishes. Duration and frequency of exposure was defined by the overlap between pollen emission and presence of larvae on host plants. Different risk scenarios are expected in the two regions: highest exposure is foreseen for A. io in the Northern site, while minimal exposure is estimated for V. cardui in the Southern site. In the latter case, locally grown maize cultivars flower in mid‐summer in coincidence with an aestivation period for several butterfly species due to hot and dry conditions. Moreover, host plants of V. cardui are at the end of their life cycle thus limiting food availability.     

转基因抗虫作物对捕食性瓢虫的安全性研究进展

转基因抗虫作物的商业化种植带来了显著的经济、生态和社会效益,对转基因抗虫作物的安全性评价也一直是国内外学者研究的热点。对生物非靶标效应的研究是转基因抗虫作物安全性评价的重要组成部分,农田天敌类生物是其中的重点内容之一。瓢虫是农田生态系统重要的捕食性天敌,评价其在转基因抗虫作物田间是否能通过捕食猎物或取食花粉而接触到杀虫蛋白并富集于体内,进而对自身产生一定的非靶标效应,这对捕食性瓢虫的安全性研究具有重要的意义。本文从捕食性天敌瓢虫的生命表参数、行为功能参数、田间群落参数及体内微环境指标等方面综述了转基因抗虫作物对瓢虫的安全性研究进展,并对后期转基因抗虫作物对田间捕食性天敌的研究方向提出了建议,以期为转基因抗虫作物的环境安全性研究提供理论指导和为进一步完善转基因抗虫作物对瓢虫安全性评价的技术体系提供系统的数据资料。     

反转录病毒基因治疗载体及其安全性评价

反转录病毒载体是目前基因治疗中应用最广泛的基因运载工具之一,具有能稳定整合入宿主细胞、持久表达目的基因、感染细胞范围广、基因容量较大等优点,但其生物安全性还存在争议。在简要介绍反转录基因治疗病毒载体的基础上,对反转录病毒载体中外源目的基因的表达调控及反转录病毒载体的安全性评价进行了综述。     

Gene therapy in cancer

Gene therapy, recently frequently investigated, is an alternative treatment method that introduces therapeutic genes into a cancer cell or tissue to cause cell death or slow down the growth of the cancer. This treatment has various strategies such as therapeutic gene activation or silencing of unwanted or defective genes; therefore a wide variety of genes and viral or nonviral vectors are being used in studies. Gene therapy strategies in cancer can be classified as inhibition of oncogene activation, activation of tumor suppressor gene, immunotherapy, suicide gene therapy and antiangiogenic gene therapy. In this review, we explain gene therapy, gene therapy strategies in cancer, approved gene medicines for cancer treatment and future of gene therapy in cancer. Today gene therapy has not yet reached the level of replacing conventional therapies. However, with a better understanding of the mechanism of cancer to determine the right treatment and target, in the future gene therapy, used as monotherapy or in combination with another existing treatment options, is likely to be used as a new medical procedure that will make cancer a controllable disease.     

Natural and released inoculum levels of entomopathogenic fungal biocontrol agents in soil in relation to risk assessment and in accordance with EU regulations

Entomopathogenic fungi being developed as biological control agents (BCAs) may have the potential to spread and become established in the environment. For registration purposes, the risks concerning their persistence have to be evaluated according to EU legislation which requires the decline of BCAs to acceptable background levels unless related risks are acceptable. In order to deal with this requirement, applicants of a BCA need to give information on its persistence and natural background levels. For risk assessors and registration authorities guidance on how to evaluate data on natural background levels of indigenously occurring species (=same species as the introduced BCA) is needed. For this purpose, an overview is presented on background levels of some indigenous fungi as well as persistence data of some applied fungal BCAs. Data were restricted to commerical species. It was found that for the species Metarhizium anisopliae, Beauveria bassiana and Beauveria brongniartii natural densities were relatively low and introduced strains of these fungi decreased gradually in time. Many factors were found in the literature, such as intrinsic, edaphic, biotic, climatic, and cultural factors, that could explain this decline.     

Molecular identification targeting cox1 and 18S genes confirms the high prevalence of Sarcocystis spp. in cattle in the Netherlands

The reported prevalence of Sarcocystis infection in cattle in Europe ranges between 66 and 94%. Although in the Netherlands a prevalence of 100% was reported in 1993, this study aimed to develop a method for sensitive and specific molecular detection and species identification of Sarcocystis spp., in order to provide more recent data on the prevalence and identification of these protozoa in cattle meat intended for human consumption in the Netherlands. For this purpose, 104 cattle samples were obtained from Dutch slaughterhouses. Genomic DNA was extracted, and analysed by 18S and cox1 PCR. Magnetic capture was used to extract and amplify 18S-specific DNA. Sarcocystis DNA was detected in 82.7% of the samples. PCR amplicons of both targets were sequenced, and sequence identities of ≥97% were observed for Sarcocystis cruzi (65.4%), Sarcocystis hominis (12.5%), Sarcocystis bovifelis (8.7%), Sarcocystis hirsuta and Sarcocystis heydorni (both 1.0%). Mixed infections were observed in 17.3% of the samples. The magnetic capture was not significantly more sensitive compared with standard DNA extraction, but magnetic capture did add to the overall sensitivity. Using cox1 sequencing, all species are clearly distinguished, whereas for 18S the variation between species is limited, which particularly hampers reliable identification of thick walled Sarcocystis spp. Furthermore, the detection of 12.5% S. hominis and 1% S. heydorni points towards an established transmission route between cattle and humans in the Netherlands. The availability of four additional well-identified and well-referenced S. hominis cox1 sequences in public databases enables development of species-specific diagnostic PCRs targeting cox1, which in combination with magnetic capture could provide the means to determine the prevalence of human sarcocystosis.     

History of diatom research in The Netherlands and Flanders

The history of diatom research in The Netherlands and Flanders is summarized in this report. A. van Leeuwenhoek observed diatoms as early as 1702. The first inventories were made in The Netherlands by R. B. van den Bosch (1846) and in Flanders by J.-J. Kickx (1867). Diatoms were already used in geological research in the second half of the nineteenth century. The Synopsis by H. van Heurck (1880–1885) enabled many twentieth century workers to do applied research for geological and ecological purposes.     

Evaluation of the field impacts of simulated Bacillus thuringiensis‐transgenic Pinus radiata on nontarget native Lepidoptera and their natural enemies in a New Zealand plantation forest

相似文献   

Gene Expression in Bacteria Directed by Plant-specific Regulatory Sequences

The regulation of gene expression represents a specific process which has different structural and functional requirements in different groups of organisms. It is thus assumed that regulatory sequences of eucaryotes cannot be recognized in procaryotes. This assumption is of interest for risk assessments of the environmental impact of deliberate release experiments with genetically modified organisms. In order to analyse the extent of heterologous gene expression caused by the transfer of plant-specific regulatory sequences into bacteria, we constructed fusions between plant-specific regulatory sequences and the coding regions of the luxAB genes for the luciferase of the bioluminescent bacterium Vibrio harveyi, transferred the fusions into different bacterial species and measured the luminescence to quantify the expression of the luciferase genes. The regulatory sequences investigated included (a) the 35S promoter of the Cauliflower mosaic virus, (b) the B33 promoter of a class I patatin gene of potatoes, (c) the promoter of the ST-LS1 gene of potatoes and (d) the promoter of the rolC gene of Agrobacterium rhizogenes. We could show that in addition to the 35S promoter, which has already been described as being recognized in Escherichia coli, the sequences containing the B33 and the ST-LS1 promoters are recognized in bacteria. Luciferase gene expression promoted by the sequence with the ST-LS1 promoter could be observed in E. coli, Yersinia enterocolitica and Agrobacterium tumefaciens. Comparison of the luminescence caused by fusions between luxAB and different promoters on the chromosome and on an endogenous plasmid of Y. enterocolitica demonstrated that the level of the heterologous gene expression caused by the fragment with the ST-LS1 promoter was within the range of gene expression levels caused by endogenous promoters of Y. enterocolitica.